Hepatic lipid metabolic pathways modified by resveratrol in rats fed an obesogenic diet

Nutrition

Volumn 29, Issue 3, 2013, Pages 562-567

  Alberdi, Goiuri ^a   Rodríguez, Víctor M ^a   Macarulla, M Teresa ^a   Miranda, Jonatan ^a   Churruca, Itziar ^a   Portillo, María P ^a  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

Author keywords

Fatty acid oxidation; Lipogenesis; Liver; Rat; Resveratrol

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; ACYL COENZYME A OXIDASE; CARNITINE PALMITOYLTRANSFERASE I; CARNITINE PALMITOYLTRANSFERASE IA; CYTOCHROME C OXIDASE; CYTOCHROME C OXIDASE SUBUNIT 2; FATTY ACID SYNTHASE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; HEPATOCYTE NUCLEAR FACTOR 4ALPHA; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; INSULIN; MALATE DEHYDROGENASE (DECARBOXYLATING); MITOCHONDRIAL TRANSCRIPTION FACTOR A; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; RESVERATROL; SIRTUIN 1; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOCHROME C OXIDASE SUBUNIT 2 GENE; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE EXPRESSION; GENETIC ANALYSIS; HEPATOCYTE NUCLEAR FACTOR 4ALPHA GENE; INSULIN BLOOD LEVEL; LIPID DIET; LIPID LIVER LEVEL; LIPID METABOLISM; LIPID OXIDATION; LIPID STORAGE; MALE; MITOCHONDRIAL TRANSCRIPTION FACTOR A GENE; NONHUMAN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA GENE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA GENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; SIRTUIN 1 GENE; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C GENE; SUGAR INTAKE;

ACETYLATION; ACYL-COA OXIDASE; ADENYLATE KINASE; ADIPOSE TISSUE; ANIMALS; CARNITINE O-PALMITOYLTRANSFERASE; DIET, HIGH-FAT; DIETARY SUCROSE; ENZYME ACTIVATION; FATTY ACIDS; LIPID METABOLISM; LIVER; MALE; OBESITY; OXIDATION-REDUCTION; RATS; RATS, SPRAGUE-DAWLEY; RNA-BINDING PROTEINS; SIRTUIN 1; STILBENES; TRANSCRIPTION FACTORS; TRIGLYCERIDES;

RATTUS;

EID: 84873568768     PISSN: 08999007     EISSN: 18731244     Source Type: Journal    
DOI: 10.1016/j.nut.2012.09.011     Document Type: Article

References (41)

1. Boue S.M., Cleveland T.E., Carter-Wientjes C., Shih B.Y., Bhatnagar D., McLachlan J.M., et al. Phytoalexin-enriched functional foods. J Agric Food Chem 2009, 57:2614-2622.
2. Espin J.C., Garcia-Conesa M.T., Tomas-Barberan F.A. Nutraceuticals: facts and fiction. Phytochemistry 2007, 68:2986-3008.
3. Bradamante S., Barenghi L., Villa A. Cardiovascular protective effects of resveratrol. Cardiovasc Drug Rev 2004, 22:169-188.
4. Cucciolla V., Borriello A., Oliva A., Galletti P., Zappia V., Della Ragione F. Resveratrol: from basic science to the clinic. Cell Cycle 2007, 6:2495-2510.
5. Vang O., Ahmad N., Baile C.A., Baur J.A., Brown K., Csiszar A., et al. What is new for an old molecule? Systematic review and recommendations on the use of resveratrol. PLoS One 2011, 6:e19881.
6. Macarulla M.T., Alberdi G., Gomez S., Tueros I., Bald C., Rodriguez V.M., et al. Effects of different doses of resveratrol on body fat and serum parameters in rats fed a hypercaloric diet. J Physiol Biochem 2009, 65:369-376.
7. Alberdi G., Rodriguez V.M., Miranda J., Macarulla M.T., Arias N., Andres-Lacueva C., et al. Changes in white adipose tissue metabolism induced by resveratrol in rats. Nutr Metab (Lond) 2011, 8:29.
8. Folch J., Lees M., Sloane Stanley G.H. A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 1957, 226:497-509.
9. Miranda J., Fernandez-Quintela A., Churruca I., Rodriguez V.M., Simon E., Portillo M.P. Hepatomegaly induced by trans-10, cis-12 conjugated linoleic acid in adult hamsters fed an atherogenic diet is not associated with steatosis. J Am Coll Nutr 2009, 28:43-49.
10. Zabala A., Churruca I., Macarulla M.T., Rodriguez V.M., Fernandez-Quintela A., Martinez J.A., et al. The trans-10, cis-12 isomer of conjugated linoleic acid reduces hepatic triacylglycerol content without affecting lipogenic enzymes in hamsters. Br J Nutr 2004, 92:383-389.
11. Orolin J., Vecera R., Markova I., Zacharova A., Anzenbacher P. Differences in hepatic expression of genes involved in lipid homeostasis between hereditary hypertriglyceridemic rats and healthy Wistar rats and in their response to dietary cholesterol. Food Chem Toxicol 2009, 47:2624-2630.
12. López-Soldado I., Avella M., Botham K.M. Suppression of VLDL secretion by cultured hepatocytes incubated with chylomicron remnants enriched in n-3 polyunsaturated fatty acids is regulated by hepatic nuclear factor-4α. Biochim Biophys Acta 2009, 1791:1181-1189.
13. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001, 25:402-408.
14. Wang G.L., Fu Y.C., Xu W.C., Feng Y.Q., Fang S.R., Zhou X.H. Resveratrol inhibits the expression of SREBP1 in cell model of steatosis via Sirt1-FOXO1 signaling pathway. Biochem Biophys Res Commun 2009, 380:644-649.
15. Zang M., Xu S., Maitland-Toolan K.A., Zuccollo A., Hou X., Jiang B., et al. Polyphenols stimulate AMP-activated protein kinase, lower lipids, and inhibit accelerated atherosclerosis in diabetic LDL receptor-deficient mice. Diabetes 2006, 55:2180-2191.
16. Ajmo J.M., Liang X., Rogers C.Q., Pennock B., You M. Resveratrol alleviates alcoholic fatty liver in mice. Am J Physiol Gastrointest Liver Physiol 2008, 295:G833-G842.
17. Gomez-Zorita S., Fernandez-Quintela A., Macarulla M.T., Aguirre L., Hijona E., Bujanda L., et al. Resveratrol attenuates steatosis in obese Zucker rats by decreasing fatty acid availability and reducing oxidative stress. Br J Nutr 2012, 107:202-210.
18. Bujanda L., Hijona E., Larzabal M., Beraza M., Aldazabal P., Garcia-Urkia N., et al. Resveratrol inhibits nonalcoholic fatty liver disease in rats. BMC Gastroenterol 2008, 8:40.
19. Ahn J., Cho I., Kim S., Kwon D., Ha T. Dietary resveratrol alters lipid metabolism-related gene expression of mice on an atherogenic diet. J Hepatol 2008, 49:1019-1028.
20. Barger J.L., Kayo T., Vann J.M., Arias E.B., Wang J., Hacker T.A., et al. A low dose of dietary resveratrol partially mimics caloric restriction and retards aging parameters in mice. PLoS One 2008, 3:e2264.
21. Ferramosca A., Savy V., Conte L., Zara V. Dietary combination of conjugated linoleic acid (CLA) and pine nut oil prevents CLA-induced fatty liver in mice. J Agric Food Chem 2008, 56:8148-8158.
22. Poirier H., Niot I., Clement L., Guerre-Millo M., Besnard P. Development of conjugated linoleic acid (CLA)-mediated lipoatrophic syndrome in the mouse. Biochimie 2005, 87:73-79.
23. Vyas D., Kadegowda A.K., Erdman R.A. Dietary conjugated linoleic Acid and hepatic steatosis: species-specific effects on liver and adipose lipid metabolism and gene expression. J Nutr Metab 2012, 2012:932928.
24. Wanders A.J., Leder L., Banga J.D., Katan M.B., Brouwer I.A. A high intake of conjugated linoleic acid does not affect liver and kidney function tests in healthy human subjects. Food Chem Toxicol 2010, 48:587-590.
25. Gómez-Zorita S., Fernández-Quintela A., Macarulla M.T., Aguirre L., Hijona E., Bujanda L., et al. Resveratrol attenuates steatosis in obese Zucker rats by decreasing fatty acid availability and reducing oxidative stress. Br J Nutr 2012, 107:202-210.
26. Hayhurst G.P., Lee Y.H., Lambert G., Ward J.M., Gonzalez F.J. Hepatocyte nuclear factor 4alpha (nuclear receptor 2A1) is essential for maintenance of hepatic gene expression and lipid homeostasis. Mol Cell Biol 2001, 21:1393-1403.
27. Baur J., Pearson K., Price N., Jamieson H., Lerin C., Kalra A., et al. Resveratrol improves health and survival of mice on a high-calorie diet. Nature 2006, 444:337-342.
28. E L., Lu J., Burns J.M., Swerdlow R.H. Effect of exercise on mouse liver and brain bioenergetic infrastructures. Exp Physiol 2012, (in press).
29. Norrbom J., Sundberg C.J., Ameln H., Kraus W.E., Jansson E., Gustafsson T. PGC-1alpha mRNA expression is influenced by metabolic perturbation in exercising human skeletal muscle. J Appl Physiol 2004, 96:189-194.
30. Zhang Q., Wu Y., Zhang P., Sha H., Jia J., Hu Y., et al. Exercise induces mitochondrial biogenesis after brain ischemia in rats. Neuroscience 2012, 205:10-17.
31. Sutherland L.N., Bomhof M.R., Capozzi L.C., Basaraba S.A.U., Wright D.C. Exercise and adrenaline increase PGC-1α mRNA expression in rat adipose tissue. J Physiol 2009, 587:1607-1617.
32. Munday M.R. Regulation of mammalian acetyl-CoA carboxylase. Biochem Soc Trans 2002, 30:1059-1064.
33. Wang Y.X., Lee C.H., Tiep S., Yu R.T., Ham J., Kang H., et al. Peroxisome-proliferator-activated receptor delta activates fat metabolism to prevent obesity. Cell 2003, 113:159-170.
34. Medina-Gomez G., Gray S., Vidal-Puig A. Adipogenesis and lipotoxicity: role of peroxisome proliferator-activated receptor gamma (PPARgamma) and PPARgammacoactivator-1 (PGC1). Public Health Nutr 2007, 10:1132-1137.
35. Shang J., Chen L.L., Xiao F.X., Sun H., Ding H.C., Xiao H. Resveratrol improves non-alcoholic fatty liver disease by activating AMP-activated protein kinase. Acta Pharmacol Sin 2008, 29:698-706.
36. Hwang J.T., Kwon D.Y., Yoon S.H. AMP-activated protein kinase: a potential target for the diseases prevention by natural occurring polyphenols. N Biotechnol 2009, 26:17-22.
37. Hou X., Xu S., Maitland-Toolan K.A., Sato K., Jiang B., Ido Y., et al. SIRT1 regulates hepatocyte lipid metabolism through activating AMP-activated protein kinase. J Biol Chem 2008, 283:20015-20026.
38. Pacholec M., Bleasdale J.E., Chrunyk B., Cunningham D., Flynn D., Garofalo R.S., et al. SRT1720, SRT2183, SRT1460, and resveratrol are not direct activators of SIRT1. J Biol Chem 2010, 285:8340-8351.
39. Canto C., Jiang L.Q., Deshmukh A.S., Mataki C., Coste A., Lagouge M., et al. Interdependence of AMPK and SIRT1 for metabolic adaptation to fasting and exercise in skeletal muscle. Cell Metab 2010, 11:213-219.
40. Um J.H., Park S.J., Kang H., Yang S., Foretz M., McBurney M.W., et al. AMP-activated protein kinase-deficient mice are resistant to the metabolic effects of resveratrol. Diabetes 2010, 59:554-563.
41. Rivera L., Moron R., Zarzuelo A., Galisteo M. Long-term resveratrol administration reduces metabolic disturbances and lowers blood pressure in obese Zucker rats. Biochem Pharmacol 2009, 77:1053-1063.